Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Understanding why budgets fail can help you avoid common mistakes. Explore these reasons to strengthen your budgeting approach.
19,896 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
In a hypothetical scenario, Gemini faces a class-action suit after pivoting to prediction markets. Investors wonder i...
Dream Finders has offered cash to acquire Beazer at roughly $32 per share, elevating the stakes for both companies. T...
A billionaire hedge fund manager shows the power of high-conviction bets in AI. This article breaks down Ackman'...
Florida’s housing market stays competitive for first-time buyers as lenders compete on speed, cost, and support. Here...
United Airlines will cut about 5% of capacity this quarter as jet fuel prices climb amid geopolitical tensions. The m...
A sharp look at how Rivian Automotive and Tesla earn money, where their revenue comes from, and what the trends mean ...
Alibaba heads into 2026 with two clear catalysts. This analysis lays out the two big predictions, explains why they c...
Micron’s blowout quarter ignited a rally that dwarfed many peers, but the broader memory-chip sector lifted a key ETF...
A Texas Capital BancShares board member purchased 1,000 shares at $91.50 per share as the stock price weakened. This ...
A ChatGPT-powered forecast associated with Sam Altman lays out a bullish Bitcoin scenario for late 2026, highlighting...
Nvidia sits at a potential turning point, guided by a history of cycles tied to AI and data centers. This article unf...